Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term 'multiple' does not refer to a specific biological target, receptor, enzyme, or protein. In pharmacological and biomedical literature, it is typically used as a placeholder or a descriptive term to indicate that a drug or compound interacts with a variety of different molecular entities, a phenomenon known as polypharmacology (Source: NCBI, PMC2715281). Because it lacks a unique molecular identity or a corresponding gene symbol, it cannot be characterized by standard biological functions or specific disease roles. This entry is considered incorrect for target-specific data structures as it does not provide the necessary information to identify a single therapeutic target.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple.